IBDEI1LE ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,28264,1,5,0)
 ;;=5^Family H/O Cancer Of Lung
 ;;^UTILITY(U,$J,358.3,28264,2)
 ;;=^295293
 ;;^UTILITY(U,$J,358.3,28265,0)
 ;;=V19.6^^162^1794^1
 ;;^UTILITY(U,$J,358.3,28265,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28265,1,4,0)
 ;;=4^V19.6
 ;;^UTILITY(U,$J,358.3,28265,1,5,0)
 ;;=5^Family H/O Allergic Disorder
 ;;^UTILITY(U,$J,358.3,28265,2)
 ;;=^295326
 ;;^UTILITY(U,$J,358.3,28266,0)
 ;;=V18.2^^162^1794^2
 ;;^UTILITY(U,$J,358.3,28266,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28266,1,4,0)
 ;;=4^V18.2
 ;;^UTILITY(U,$J,358.3,28266,1,5,0)
 ;;=5^Family H/O Anemia
 ;;^UTILITY(U,$J,358.3,28266,2)
 ;;=^295313
 ;;^UTILITY(U,$J,358.3,28267,0)
 ;;=V17.5^^162^1794^4
 ;;^UTILITY(U,$J,358.3,28267,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28267,1,4,0)
 ;;=4^V17.5
 ;;^UTILITY(U,$J,358.3,28267,1,5,0)
 ;;=5^Family H/O Asthma
 ;;^UTILITY(U,$J,358.3,28267,2)
 ;;=^295307
 ;;^UTILITY(U,$J,358.3,28268,0)
 ;;=V17.7^^162^1794^3
 ;;^UTILITY(U,$J,358.3,28268,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28268,1,4,0)
 ;;=4^V17.7
 ;;^UTILITY(U,$J,358.3,28268,1,5,0)
 ;;=5^Family H/O Arthritis
 ;;^UTILITY(U,$J,358.3,28268,2)
 ;;=^295309
 ;;^UTILITY(U,$J,358.3,28269,0)
 ;;=V19.0^^162^1794^5
 ;;^UTILITY(U,$J,358.3,28269,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28269,1,4,0)
 ;;=4^V19.0
 ;;^UTILITY(U,$J,358.3,28269,1,5,0)
 ;;=5^Family H/O Blindness
 ;;^UTILITY(U,$J,358.3,28269,2)
 ;;=^295320
 ;;^UTILITY(U,$J,358.3,28270,0)
 ;;=V16.3^^162^1794^6
 ;;^UTILITY(U,$J,358.3,28270,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28270,1,4,0)
 ;;=4^V16.3
 ;;^UTILITY(U,$J,358.3,28270,1,5,0)
 ;;=5^Family H/O Cancer Of Breast
 ;;^UTILITY(U,$J,358.3,28270,2)
 ;;=^295295
 ;;^UTILITY(U,$J,358.3,28271,0)
 ;;=V16.41^^162^1794^9
 ;;^UTILITY(U,$J,358.3,28271,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28271,1,4,0)
 ;;=4^V16.41
 ;;^UTILITY(U,$J,358.3,28271,1,5,0)
 ;;=5^Family H/O Cancer Of Ovary
 ;;^UTILITY(U,$J,358.3,28271,2)
 ;;=^317951
 ;;^UTILITY(U,$J,358.3,28272,0)
 ;;=V16.42^^162^1794^10
 ;;^UTILITY(U,$J,358.3,28272,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28272,1,4,0)
 ;;=4^V16.42
 ;;^UTILITY(U,$J,358.3,28272,1,5,0)
 ;;=5^Family H/O Cancer Of Prostate
 ;;^UTILITY(U,$J,358.3,28272,2)
 ;;=^317952
 ;;^UTILITY(U,$J,358.3,28273,0)
 ;;=V16.43^^162^1794^11
 ;;^UTILITY(U,$J,358.3,28273,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28273,1,4,0)
 ;;=4^V16.43
 ;;^UTILITY(U,$J,358.3,28273,1,5,0)
 ;;=5^Family H/O Cancer Of Testis
 ;;^UTILITY(U,$J,358.3,28273,2)
 ;;=^317953
 ;;^UTILITY(U,$J,358.3,28274,0)
 ;;=V19.5^^162^1794^12
 ;;^UTILITY(U,$J,358.3,28274,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28274,1,4,0)
 ;;=4^V19.5
 ;;^UTILITY(U,$J,358.3,28274,1,5,0)
 ;;=5^Family H/O Congenital Anomalies
 ;;^UTILITY(U,$J,358.3,28274,2)
 ;;=^295325
 ;;^UTILITY(U,$J,358.3,28275,0)
 ;;=V19.2^^162^1794^13
 ;;^UTILITY(U,$J,358.3,28275,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28275,1,4,0)
 ;;=4^V19.2
 ;;^UTILITY(U,$J,358.3,28275,1,5,0)
 ;;=5^Family H/O Deafness Or Hearing Loss
 ;;^UTILITY(U,$J,358.3,28275,2)
 ;;=^295322
 ;;^UTILITY(U,$J,358.3,28276,0)
 ;;=V17.3^^162^1794^15
 ;;^UTILITY(U,$J,358.3,28276,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28276,1,4,0)
 ;;=4^V17.3
 ;;^UTILITY(U,$J,358.3,28276,1,5,0)
 ;;=5^Family H/O Ischemic Heart Dis
 ;;^UTILITY(U,$J,358.3,28276,2)
 ;;=^295305
 ;;^UTILITY(U,$J,358.3,28277,0)
 ;;=V16.6^^162^1794^16
 ;;^UTILITY(U,$J,358.3,28277,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,28277,1,4,0)
 ;;=4^V16.6
 ;;^UTILITY(U,$J,358.3,28277,1,5,0)
 ;;=5^Family H/O Leukemia
 ;;^UTILITY(U,$J,358.3,28277,2)
 ;;=^295298
 ;;
 ;;$END ROU IBDEI1LE
